- UsageLonsurf is indicated as monotherapy for the treatment of adult patients with metastatic colorectal cancer
- Product NameLonsurf Tablets
- MOQ1box
- Supply TypeExporter, Supplier, Retailer
- Preferred Buyer Location All over the world
Lonsurf is indicated as monotherapy for the treatment of adult patients with metastatic colorectal cancer (CRC) who have been previously treated with, or are not considered candidates for, available therapies including fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapies, anti-VEGF agents, and anti-EGFR.
View More Details